Nichol Ochsner | Vice President of Investor Relations |
Robert Finizio | Chief Executive Officer |
Daniel Cartwright | Chief Financial Officer |
Dawn Halkuff | Chief Commercial Officer |
Louise Chen | Cantor Fitzgerald |
Annabel Samimy | Stifel |
Jay Olson | Oppenheimer |
Good afternoon, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Second Quarter 2019 Financial Results Conference Call.
Following prepared remarks from the company, we will open the call for questions.
I would now like to turn the call over to TherapeuticsMD's Vice President of Investor Relations, Nichol Ochsner. Nichol?